Toll-like receptors and adaptor molecules in liver disease: update
- PMID: 18506843
- DOI: 10.1002/hep.22306
Toll-like receptors and adaptor molecules in liver disease: update
Abstract
Toll-like receptors (TLRs) are pattern recognition receptors that recognize pathogen-associated molecular patterns and signal through adaptor molecules, myeloid differentiation factor 88 (MyD88), Toll/IL-1 receptor domain containing adaptor protein (TIRAP), Toll/IL-1 receptor domain containing adaptor inducing interferon-beta (TRIF), and TRIF-related adaptor molecule (TRAM) to activate transcription factors, nuclear factor (NF)-kappaB, activator protein 1 (AP-1), and interferon regulatory factors (IRFs) leading to the initiation of innate immunity. This system promptly initiates host defenses against invading microorganisms. Endogenous TLR ligands such as the products from dying cells may also engage with TLRs as damage-associated molecular patterns. Although Kupffer cells are considered the primary cells to respond to pathogen associated molecular patterns in the liver, recent studies provide evidence of TLR signaling in hepatic nonimmune cell populations, including hepatocytes, biliary epithelial cells, endothelial cells, and hepatic stellate cells. This review highlights advances in TLR signaling in the liver, the role of TLRs in the individual hepatic cell populations, and the implication of TLR signaling in acute and chronic liver diseases. We further discuss recent advances regarding cytosolic pattern recognition receptors, RNA helicases that represents a new concept in chronic hepatitis C virus infection.
Similar articles
-
Toll-like receptor and RIG-I-like receptor signaling.Ann N Y Acad Sci. 2008 Nov;1143:1-20. doi: 10.1196/annals.1443.020. Ann N Y Acad Sci. 2008. PMID: 19076341 Review.
-
The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.J Hepatol. 2011 Oct;55(4):762-9. doi: 10.1016/j.jhep.2010.12.042. Epub 2011 Feb 18. J Hepatol. 2011. PMID: 21334391
-
TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.J Cell Biochem. 2007 Apr 1;100(5):1301-12. doi: 10.1002/jcb.21119. J Cell Biochem. 2007. PMID: 17243100
-
Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages.J Leukoc Biol. 2009 May;85(5):751-65. doi: 10.1189/jlb.0708405. Epub 2009 Feb 13. J Leukoc Biol. 2009. PMID: 19218482
-
Signalling of toll-like receptors.Handb Exp Pharmacol. 2008;(183):21-50. doi: 10.1007/978-3-540-72167-3_2. Handb Exp Pharmacol. 2008. PMID: 18071653 Review.
Cited by
-
Pathophysiology of NASH: perspectives for a targeted treatment.Curr Pharm Des. 2013;19(29):5250-69. doi: 10.2174/13816128113199990344. Curr Pharm Des. 2013. PMID: 23394092 Free PMC article.
-
The Battle of LPS Clearance in Host Defense vs. Inflammatory Signaling.Cells. 2024 Sep 21;13(18):1590. doi: 10.3390/cells13181590. Cells. 2024. PMID: 39329771 Free PMC article. Review.
-
Activation of cyclic adenosine monophosphate-dependent protein kinase a signaling prevents liver ischemia/reperfusion injury in mice.Liver Transpl. 2012 Jun;18(6):659-70. doi: 10.1002/lt.23399. Liver Transpl. 2012. PMID: 22290937 Free PMC article.
-
Updates on immunological mechanistic insights and targeting of the oral lichen planus microenvironment.Front Immunol. 2023 Jan 9;13:1023213. doi: 10.3389/fimmu.2022.1023213. eCollection 2022. Front Immunol. 2023. PMID: 36700192 Free PMC article. Review.
-
Networks inferred from biochemical data reveal profound differences in toll-like receptor and inflammatory signaling between normal and transformed hepatocytes.Mol Cell Proteomics. 2010 Sep;9(9):1849-65. doi: 10.1074/mcp.M110.000406. Epub 2010 May 10. Mol Cell Proteomics. 2010. PMID: 20460255 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials